The biotech sector deflated, as most sectors did, in the first half of 2022. However, the sector is in the midst of a comeback as mergers and acquisitions rise, signaling increased activity. The biotech sector wasn’t immune to inflation fears to start 2022. While the sector has been making a comeback in recent months, the [...] The post Biotech Bounces in August as M&A Activity Increases appeared first on ETF Trends .